期刊文献+

血清血管生成因子预测子痫前期患病风险的价值 被引量:4

The value of serum angiogenic factors for predicating development of preeclampsia
原文传递
导出
摘要 目的探讨中期妊娠血清可溶性血管内皮生长因子受体1(sFlt-1)、可溶性内皮因子(sEng)及胎盘生长因子(PLGF)水平预测子痫前期的价值。方法用ELISA检测子痫前期(A组,57例)和正常妊娠(B组,43例)孕妇妊娠中期血清sFlt-1、sEng和PLGF水平。结果 A组血清sFlt-1、sEng浓度高于B组,血清PLGF浓度低于B组(P<0.01);A组sFlt-1、sEng与PLGF水平分别呈负相关,sFlt-1与sEng水平呈正相关(P<0.01)。在妊娠中期,sFlt-1/PLGF比值>1.9时,预测子痫前期的敏感性为89.5%,特异性88.4%;sEng/PLGF比值>15.6,预测子痫前期的敏感性为84.2%,特异性86.1%;(sEng+sFlt-1)/PLGF比值>16.9,预测子痫前期的敏感性为93.0%,特异性为95.3%。结论妊娠中期检测血清sFlt-1、sEng和PLGF水平可有助于预测子痫前期。 Objective To investigate the value of serum angiogenic factors for predicating development of preeclampsia during the second trimester. Methods Serum soluble fms-like tyrosine kinase-1(sFlt-1),soluble endoglin(sEng) and placenta growth factor(PLGF) were detected using ELISA in 57 preeclampsia pregnant women(group A) and 43 pregnat women without preeclampsia(group B). Results Serum levels of sFlt-1 and sEng were significantly higher,but serum PLGF was lower,in Group A than those in group B(P0.01).Serum sFlt-1 and sEng were negatively correlated with PlGF,and sFlt-1 was positively correlated with sEng in group A(P0.01).As early markers for predicting the development of preeclampsia in the second trimester,the ratio of sFlt-1/PLGF1.9,sEng/PLGF15.6,and(sEng+sFlt-1)/PLGF16.9 showed the sensitivity and specificity of 89.5% and 88.4%,88.4% and 86.1%,and 93.0% and 95.3%,respectively. Conclusion In the second trimester,detection of serum sFlt-1,sEng and PLGFP is helpful in predicting the development of preeclampsia.
出处 《江苏医药》 CAS CSCD 北大核心 2012年第1期40-42,共3页 Jiangsu Medical Journal
基金 常州市卫生局规划项目(WZ201028)
关键词 胎盘生长因子 血管内皮生长因子受体1 可溶性内皮因子 子痫前期 Placenta growth factor Soluble fms-like tyrosine kinase-1 soluble endoglin Preeclampsia
  • 相关文献

参考文献8

  • 1Levine RJ,Maynard SE,Qian C,et al.Circulating angiogenicfactors and the risk of preeclampsia[J].N Engl J Med,2004,350(7):672-683.
  • 2Levine RJ,Lam C,Qian C,et al.Soluble endoglin and othercirculating antiangiogenic factors in preeclampsia[J].N Engl JMed,2006,350(10):992-1005.
  • 3张一鸣,袁小松,蒋丽霞,蒋雅琴.子痫前期患者血清胎盘生长因子及可溶性血管内皮生长因子受体1表达及意义[J].江苏医药,2010,36(22):2639-2642. 被引量:3
  • 4乐杰主编.妇产科学[M].第7版.北京:人民卫生出版社,2009.271-272.
  • 5Conde-Agudelo A,Villar J,Lindheimer M.World HealthOrganization systematic review of screening tests for pre-eclampsia[J].Obstet Gynecol,2004,104(6):1367-1391.
  • 6Zhong Y,Tuuli M,Odibo AO.First-trimester assessment ofplacenta function and the prediction of preeclampsia and intrau-terine growth restriction[J].Prenat Diagn,2010,30(4):293308.
  • 7Li DY,Sorensen LK,Brooke BS,et al.Defective angiogenesisin mice lacking endoglin[J].Science,1999,284(5419):1534-1537.
  • 8Venkatesha S,Toporsian M,Lam C,et al.Soluble endoglincontributes to the pathogenesi s of preeclampsia[J].Nat Med,2006,12(6):642-649.

二级参考文献9

  • 1叶元华,刘玲,詹瑛,彭伟.可溶性血管内皮生长因子受体1在子痫前期患者胎盘组织中的表达及意义[J].中华妇产科杂志,2006,41(8):521-524. 被引量:7
  • 2乐杰,谢幸,等主编.妇产科学[M].第7版.北京:人民卫生出版社,2009.241.
  • 3Sibai B,Dekker G,Kupferminc M. Pre-eelampsia[J]. Lancet, 2005,94(61) : 785-799.
  • 4Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia[J]. N Engl J Med,2004, 350(7) : 672-683.
  • 5Huppertz B. The feto-maternal interface: setting the stage for potential immune interactions[J]. Semin Immunopathol,2007, 29(2) :83- 94.
  • 6Soleymanlou N,Jurisica I, Nevo O, et al. Molecular evidence of placental hypoxia in preeclampsia [J]. J Clin Endocrinol Metab, 2005,90 (7) : 4299-4308.
  • 7Redman CW, Sargent IL. Latest advances in understanding preeciampsia[J]. Science,2005,308(5728) : 1592-1594.
  • 8Romero R, Nien JK, Espinoza J, et al. A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-i) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate[J]. J Matern Fetal Neonatal Med, 2008,21 (1) : 9-23.
  • 9Zhou Y, MeMaster M, Woo K, et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survivalare dysregulated in severe preeclampsia and hemolysis, elevated liver and low platelets syndrome[J]. Am J Pathoh 2002,160(4) :1405-1423.

共引文献47

同被引文献34

  • 1边旭明.先兆子痫的预测:血管生成调节因子[J].中国产前诊断杂志(电子版),2012(3):15-15. 被引量:2
  • 2乐杰,谢幸,等主编.妇产科学[M].第7版.北京:人民卫生出版社,2009.241.
  • 3Goldenberg RL,Culhane JF,Iams JD,et al.Epidemiology andcauses of preterm birth[J].Lancet,2008,371(9606):75-84.
  • 4Levine RJ,Maynard SE,Qian C,et al.Circulating angiogenicfactors and the risk of preeclampsia[J].N Engl J Med,2004,350(7):672-683.
  • 5Levine RJ,Lam C,Qian C,et al.Soluble endoglin and othercirculating antiangiogenic factors in preeclampsia[J].N Engl JMed,2006,350(10):992-1005.
  • 6Anderson UD,Olsson MG,Kristensen KH,et al.Review:biochemical markers to predict preeclampsia[J].Placenta,2012,33(Suppl):S42-S47.
  • 7Verlohren S,Herraiz I,Lapaire O,et al.The sFlt-1/PlGF ratioin different types of hypertensive pregnancy disorders and itsprognostic potential in preeclamptic patients[J].Am J ObstetGynecol,2012,206(58):e1-e8.
  • 8Benton SJ,Hu Y,Xie F,et al.Angiogenic factors as diagnostictests for preeclampsia:aperformance comparison between twocommercial immunoassays[J].Am J Obstet Gynecol,2011,205(469):e1-e8.
  • 9熊维玲,周春.血管生成素与妊娠[J].国际妇产科学杂志,2009,36(1):8-10. 被引量:7
  • 10聂改红,邢军,高霞.血管生成素-2与子痫前期的相关性研究[J].实用医学杂志,2009,25(22):3825-3827. 被引量:3

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部